In a prospective study, CA 125 and CA 19.9 serum levels were measured in 229 patients
with ovarian cancer [121 with active disease, 108 in complete remission (CR)], and in 20 …

The prognostic significance of the serum CA 125 level was studied in 687 patients with
invasive epithelial ovarian malignancies. The samples were collected preoperatively in 200 …

Serum CA 125 levels and surgical findings were prospectively compared in 96 secondary
laparotomies performed on patients with epithelial ovarian cancer. All patients had …

In a retrospective study 121 patients with endometrial cancer were examined. In addition, 20
primary endometrial adenocardinomas were tested immunohistochemically for CA 125. All …

The prognostic significance of serum CA 125 level before treatment of relapse for invasive
epithelial ovarian cancer has been evaluated in 135 patients. At time of relapse, serum CA …

CA 125, which is an antigenic determinant expressed by many epithelial ovarian cancers, is
measured in serum using a solid phase immunoradiometric assay. Sera from 55 patients …

A number of studies have suggested that serum CA 125 levels may be an important
prognostic factor for survival of patients with ovarian carcinoma. We investigated, in a large …

The predictive value of CA 125 assay for recurrence in ovarian cancer patients in follow-up
was analyzed in a study from April 1984 through June 1987. Forty-two patients with no …

The sensitivity and specificity of CA 125 were evaluated retrospectively in 328 patients,
some of them with several diseases, seen between January, 1985 and December, 1986 …

The presence of CA 125, an ovarian cancer‐associated antigen, was assessed in serum
and ascites from patients with ovarian cancer (n= 47), hepatocellular carcinoma (n= 21), and …